Oral administration of rutoside can ameliorate inflammatory bowel disease in rats
Authors:
- J. GálvezJ. Gálvez
- M.A. OceteMOM.A. Ocete
- M.E. CrespoMCM.E. Crespo
- F.L.-H. Sánchez de MedinaFMF.L.-H. Sánchez de Medina
- A. ZarzueloAZA. Zarzuelo
- 1 January 1998
- journal article
- Published by Elsevier in Life Sciences
- Vol. 62 (7) , 687-695
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel diseaseDigestive Diseases and Sciences, 1996
- Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.Gut, 1996
- Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in ratsDigestive Diseases and Sciences, 1996
- Neutrophil-independence of the initiation of colonic injuryDigestive Diseases and Sciences, 1994
- Cellular and molecular immunology and biochemistry of inflammatory bowel diseaseCurrent Opinion in Gastroenterology, 1993
- Antidiarrhoeic activity of quercitrin in mice and ratsJournal of Pharmacy and Pharmacology, 1993
- Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidationBiochemical Pharmacology, 1990
- [70] Determination of glutathione and glutathione disulfide in biological samples1985
- Flavonoids, a class of natural products of high pharmacological potencyBiochemical Pharmacology, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976